|
| Issue Date | Title | Author(s) |
| 2024 | Advances in non-Hydroxamate based Histone Deacetylase Inhibitors as Anticancer Agents | Nabih, Nadine W; Jaballah, Maiy Y; Serya, Rabah ; Abouzid, Khaled AM |
| Jun-2024 | Advances in the discovery of activin receptor-like kinase 5 (ALK5) inhibitors | Mansour, Mai A; Hassan, Ghaneya S; Jaballah, Maiy Y; Abouzid, Khaled A M; Serya, Rabah |
| 2025 | Chalcones Tethered with Pyridylmethyloxy Tail: Unlocking New Pathways in MDM2-p53 Targeted Cancer Treatment | Alnaeb, Suha; Jaballah, Maiy Y; Morsy, Mohamed A; Abouzid, Khaled AM; Nermin Samir ; Adel, Mai |
| Oct-2025 | Design, synthesis and biological evaluation of triazolo[1,5-a]pyrimidine derivatives as new antiproliferative agents with multikinase inhibitory activity | Eldeeb, Assem H; Shahin, Mai I. ; Jaballah, Maiy Y; Elaraby, Ahmed R; Ibrahim, Tamer M; Elaasser, Mahmoud M; Abdel-Aziz, Hatem A; Lasheen, Deena S. ; Abou El Ella, Dalal A |
| Sep-2025 | Discovery of Furopyrimidine-Pyrazole Hybrid Compounds Targeting p53-MDM2 Interaction as Anticancer Agents | Mansour, Mai A; Hassan, Ghaneya S; Jaballah, Maiy Y; Dege, Necmi; Şahin, Onur; Sharaky, Marwa; Zhang, Xiaoliang; Su, Ruixin; Kong, Dexin; Abouzid, Khaled A M; Serya, Rabah |
| 2023 | Hit Identification Against Candida Albicans: Design, Synthesis, Molecular Docking and Biological Evaluation of Hybrid Styryl-Quinoxaline Based Analogues. | Jaballah, Maiy Y; Alaraby, Mohamed; Serya, Rabah ; Abouzid, Khaled |
| 2025 | The recent advances in benzimidazole-based antimicrobials and antitubercular agents | Tarek, Abdalrahman; Jaballah, Maiy Y; Elrazaz, Eman Z; Nermin Samir |
| Dec-2019 | Towards discovery of novel scaffold with potent antiangiogenic activity; design, synthesis of pyridazine based compounds, impact of hinge interaction, and accessibility of their bioactive conformation on VEGFR-2 activities | Jaballah, Maiy Y; Serya, Rabah ; Saad, Nasser; Khojah, Sohair M; Ahmed, Marawan; Barakat, Khaled; Khaled A M Abouzid |
